Cargando…

Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients

Lung adenocarcinoma (LADC) is a major subtype of lung cancer, particularly among populations of East Asia. The epidermal growth factor receptor (EGFR) is the most frequently mutated oncogene promoting LADC progression and can serve as a therapeutic target in LADC. The tissue inhibitor of metalloprot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jer-Hwa, Lai, Tsung-Ching, Yang, Po-Jen, Shih, Pei-Chun, Yang, Yi-Chieh, Lee, Kai-Ling, Liu, Tu-Chen, Tsao, Thomas Chang-Yao, Yang, Shun-Fa, Chien, Ming-Hsien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662501/ https://www.ncbi.nlm.nih.gov/pubmed/33126605 http://dx.doi.org/10.3390/ijms21218023

Ejemplares similares

Association of EGFR mutations and HMGB1 genetic polymorphisms in lung adenocarcinoma patients
por: Wu, Yi-Liang, et al.
Publicado: (2019)

Genetic Associations of Visfatin Polymorphisms with EGFR Status and Clinicopathologic Characteristics in Lung Adenocarcinoma
por: Chang, Sunny Li-Yun, et al.
Publicado: (2022)

Effect of WW Domain-Containing Oxidoreductase Gene Polymorphism on Clinicopathological Characteristics of Patients with EGFR Mutant Lung Adenocarcinoma in Taiwan
por: Li, Ju-Pi, et al.
Publicado: (2021)

Potential Impacts of Interleukin-17A Promoter Polymorphisms on the EGFR Mutation Status and Progression of Non-Small Cell Lung Cancer in Taiwan
por: Lee, Kai-Ling, et al.
Publicado: (2021)

Genetic Variants of lncRNA MALAT1 Exert Diverse Impacts on the Risk and Clinicopathologic Characteristics of Patients with Hepatocellular Carcinoma
por: Yuan, Lan-Ting, et al.
Publicado: (2019)

Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma
por: Yang, Po-Jen, et al.
Publicado: (2020)

Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chung, Tsung-Te, et al.
Publicado: (2012)

FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan
por: Li, Ju-Pi, et al.
Publicado: (2020)

Association between EGFR Gene Mutation and Antioxidant Gene Polymorphism of Non-Small-Cell Lung Cancer
por: Lin, Ching-Hsiung, et al.
Publicado: (2020)

Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Yong, Kok-Khun, et al.
Publicado: (2016)

The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma
por: Wang, Yao-Chen, et al.
Publicado: (2021)

Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan
por: Huang, Chun-Yao, et al.
Publicado: (2018)

Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer
por: Lee, Kai-Ling, et al.
Publicado: (2023)

The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics
por: Huang, Hsien-Cheng, et al.
Publicado: (2022)

CD44 Gene Polymorphisms as a Risk Factor for Susceptibility and Their Effect on the Clinicopathological Characteristics of Lung Adenocarcinoma in Male Patients
por: Li, Ju-Pi, et al.
Publicado: (2020)

Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia
por: Chang, Jer-Hwa, et al.
Publicado: (2016)

Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis
por: Su, Chun-Wen, et al.
Publicado: (2019)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma
por: Lan, Yuan-Tzu, et al.
Publicado: (2021)

Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer
por: Lin, Chang-Sheng, et al.
Publicado: (2017)

Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma
por: Lee, Po-Hsin, et al.
Publicado: (2022)

TIMP-3 as a therapeutic target for cancer
por: Su, Chun-Wen, et al.
Publicado: (2019)

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma
por: Zhou, Wensheng, et al.
Publicado: (2022)

Effects of TIMP-2 Polymorphisms on Retinopathy of Prematurity Risk, Severity, Recurrence, and Treatment Response
por: Wu, Pei-Liang, et al.
Publicado: (2022)

The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance
por: Weng, Meng-Shih, et al.
Publicado: (2018)

The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
por: Huang, Yen-Hsiang, et al.
Publicado: (2022)

The Curcumin Analogue, EF-24, Triggers p38 MAPK-Mediated Apoptotic Cell Death via Inducing PP2A-Modulated ERK Deactivation in Human Acute Myeloid Leukemia Cells
por: Hsiao, Pei-Ching, et al.
Publicado: (2020)

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer
por: Wen, Yu‐Ching, et al.
Publicado: (2023)

Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
por: Wu, Shang-Gin, et al.
Publicado: (2017)

Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients
por: Hsieh, Ming-Hong, et al.
Publicado: (2022)

Impacts of CA9 Gene Polymorphisms and Environmental Factors on Oral-Cancer Susceptibility and Clinicopathologic Characteristics in Taiwan
por: Chien, Ming-Hsien, et al.
Publicado: (2012)

Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma
por: Su, Kang-Yi, et al.
Publicado: (2018)

Anti-Müllerian Hormone Gene Polymorphism is Associated with Clinical Pregnancy of Fresh IVF Cycles
por: Wu, Cheng-Hsuan, et al.
Publicado: (2019)

Correlation of E-cadherin gene polymorphisms and epidermal growth factor receptor mutation in lung adenocarcinoma
por: Huang, Chun-Yao, et al.
Publicado: (2018)

Improved survival in patients with unresectable stage III EGFR ‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors
por: Wang, Sheng‐Yuan, et al.
Publicado: (2021)

Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan
por: Huang, Yi-Wen, et al.
Publicado: (2016)

Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients
por: Yu, Ya-Yen, et al.
Publicado: (2020)

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2020)

Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer
por: Lin, Chang-Sheng, et al.
Publicado: (2017)

The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy
por: Cheng, Wen-Chien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cif0ev1jro985mts2bdk9h5l3l